Nalidixic acid, a derivative of naphthyridine, is a potent bactericidal compound whose precise mode of action is unknown. The drug was reported to be a specific inhibitor of bacterial deoxyribonucleic acid (DNA) synthesis and replication (3, 4, 5) , and of DNA repair synthesis as shown by the accumulation of small-molecularweight DNA after extensive ultraviolet (UV) irradiation (4) . Recent experiments with toluenized cells, however, have shown only inhibition at the growing fork, with no effect on repair synthesis (5) . Various enzymes involved in DNA metabolism were found not to be affected by the drug (2, 11) . When assayed in vitro no evidence could be found for direct binding of nalidixic acid to DNA (1) . Nalidixic acid resistance loci have been mapped for Escherichia coli K-12 (8), and a specific protein factor has been proposed for conferring nalidixic acid susceptibility (1) .
Our studies have shown decreased post-UV survival of E. coli plated on nalidixic acid, without a corresponding inhibition of liquid holding recovery after UV, but with complete photorecovery (M. Nishida, N. Nakamura, and K. L. Yielding, manuscript in preparation). In an attempt to localize this presumed drug effect on UV repair, we have found that Ts-7, a mutant of E. coli TAU-bar (9, 10) displaying impaired DNA ligase function and UV susceptibility at elevated temperature, also shows an increased thermal susceptibility in the presence of nalidixic acid. These results are reported here with the hope they will provide an additional clue to the locus of drug action.
The temperature-sensitive mutant Ts-7 derived from E. coli TAU-bar grows normally at 25 C but shows a time-dependent loss of viability with initial growth above 40 C (9, 10). Both strains were kindly supplied to us by Roy Curtiss of this institution. Cells were grown to late log phase in tryptone broth (10 g of tryptone I Present address: Department of Biochemistry, University of Tokushima, Shomachi 1, Tokushima City (770), Japan.
[Difco], 5 g of NaCl) with shaking at 25 C, diluted to appropriate density with 0.9% NaCl, and plated on tryptone-NaCl agar (1.5% agar) with and without added nalidixic acid. An initial period of incubation at 40 C followed by continued culture at 25 C was employed to express the temperature sensitivity. The sequences of incubat'on temperatures and drug concentrations are indicated in the legends.
The dose response curve for Ts-7 ( Fig. .1) showed that survival at 25 C was unaffected by drug concentrations below 5 x 10-6 M. However, this concentration of drug was found to produce a sharp increase in the time-dependent loss of viability resulting from an initial period of growth at 40 C in the mutant, but not in the parent strain (Fig. 2) . This difference in susceptibility was also reflected in a change in the apparent dose response curve of Ts-7 for nalidixic acid when plates were incubated initially at 40 C prior to culture at 25 C (Fig. 3) . Strain N-1635, a temperature-sensitive ligase mutant studied in Gellert's laboratory (6), was obtained from Rolf Sternglanz and, unlike Ts-7, did not show any increase in susceptibility to nalidixic acid at 40 C (data not shown). These results suggested that the target of action for nalidixic acid corresponds to the temperature-sensitive target of Ts-7. An alternate explanation would be that the thermal insult has made the organism more susceptible to nalidixic acid. This possibility was tested by applying filter paper disks containing the drug at 10-3 M on innoculated plates immediately and after preliminary innoculation at 25 or 40 C. These results indicated equal susceptibility as measured by the size of the killing circles, whether drug application followed exposure at 25 or 40 C. In contrast, application of the drug prior to incubation at 40 C produced a substantially large zone of killing. A specific replicating protein other than the classic enzymes of replication has been pro- posed as the target for nalidixic acid (1) . How this replicating protein factor is related to the product of the mutant gene of Ts-7 cannot be concluded at present, since the latter is due to temperature sensitivity of the DNA ligase itself (7, 9, 10) . The presence of the drug could conceivably labilize the temperature-sensitive ligase either by binding directly to the enzyme or to some other part of the replicative complex to influence enzyme stability. It is pertinent that nalidixic acid was reported to produce a specific impairment in production of largemolecular-weight DNA from shorter segment precursors (4), and Ts-7 showed a similar pattern of DNA synthesis at 40 C (10). 
